Pharmacotherapy for Anxiety Disorders in Children and Adolescents

Overview

Journal Dialogues Clin Neurosci

Specialty Neurology

Date 2012 Jan 26

PMID 22275849

Citations 15

Authors

Ian Kodish

Carol Rockhill

Chris Varley

Affiliations

Soon will be listed here.

Abstract

Anxiety disorders are the most common mental health diagnoses in youth, and carry risks for ongoing impairments and subsequent development of other psychiatric comorbidities into adulthood. This article discusses considerations for assessment and treatment of anxiety disorders in youth, with a focus on the evidence base of pharmacologic treatment and important clinical considerations to optimize care. We then briefly describe the impact of anxiety on neuronal elements of fear circuitry to highlight how treatments may ameliorate impairments through enhanced plasticity Overall, pharmacotherapy for anxiety disorders is effective in improving clinical symptoms, particularly in combination with psychotherapy. Response is typically seen within several weeks, yet longitudinal studies are limited. Selective serotonin reuptake inhibitors are thought to be relatively safe and effective for acute treatment of several classes of anxiety disorders in youth, with increasing evidence supporting the role of neuronal plasticity in recovery.

Citing Articles

Diet quality and anxiety: a critical overview with focus on the gut microbiome.

Basso M, Zorzan I, Johnstone N, Barberis M, Cohen Kadosh K Front Nutr. 2024; 11:1346483.

PMID: 38812941 PMC: 11133642. DOI: 10.3389/fnut.2024.1346483.

Anxiety and school avoidance in an 8-year-old child with epilepsy.

Salpekar J, Ertenu D Epilepsy Behav Rep. 2024; 26:100659.

PMID: 38532902 PMC: 10963191. DOI: 10.1016/j.ebr.2024.100659.

Clinical Practice Guidelines for Assessment and Management of Children and Adolescents Presenting with Psychiatric Emergencies.

Shah H, Somaiya M, Chauhan N, Gautam A Indian J Psychiatry. 2023; 65(2):159-174.

PMID: 37063627 PMC: 10096198. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_494_22.

Psychobiotic interventions for anxiety in young people: a systematic review and meta-analysis, with youth consultation.

Cohen Kadosh K, Basso M, Knytl P, Johnstone N, Lau J, Gibson G Transl Psychiatry. 2021; 11(1):352.

PMID: 34131108 PMC: 8206413. DOI: 10.1038/s41398-021-01422-7.

The role of the endogenous oxytocin system under psychosocial stress conditions in adolescents suffering from anxiety disorder: study protocol for a parallel group controlled trial.

Goetz L, Jarvers I, Schleicher D, Mikan K, Brunner R, Kandsperger S BMC Psychol. 2021; 9(1):61.

PMID: 33902711 PMC: 8077873. DOI: 10.1186/s40359-021-00564-z.

References

Fawcett J, Barkin R . A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. J Clin Psychiatry. 1998; 59(3):123-7. View

Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai L . Recovery of learning and memory is associated with chromatin remodelling. Nature. 2007; 447(7141):178-82. DOI: 10.1038/nature05772. View

Ernst E . The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002; 136(1):42-53. DOI: 10.7326/0003-4819-136-1-200201010-00010. View

Walkup J, Labellarte M, Riddle M, Pine D, Greenhill L, Fairbanks J . Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. J Child Adolesc Psychopharmacol. 2002; 12(3):175-88. DOI: 10.1089/104454602760386879. View

Connolly S, Bernstein G . Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007; 46(2):267-83. DOI: 10.1097/01.chi.0000246070.23695.06. View

March J, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook E . Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA. 1998; 280(20):1752-6. DOI: 10.1001/jama.280.20.1752. View

Eiland L, McEwen B . Early life stress followed by subsequent adult chronic stress potentiates anxiety and blunts hippocampal structural remodeling. Hippocampus. 2010; 22(1):82-91. DOI: 10.1002/hipo.20862. View

Wagner K, Berard R, Stein M, Wetherhold E, Carpenter D, Perera P . A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry. 2004; 61(11):1153-62. DOI: 10.1001/archpsyc.61.11.1153. View

Singh T, Prakash A, Rais T, Kumari N . Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning. Psychiatry (Edgmont). 2009; 6(10):30-4. PMC: 2790401. View

10.

Pine D . Treating children and adolescents with selective serotonin reuptake inhibitors: how long is appropriate?. J Child Adolesc Psychopharmacol. 2002; 12(3):189-203. DOI: 10.1089/104454602760386888. View

11.

Riddle M, Reeve E, Yaryura-Tobias J, Yang H, Claghorn J, Gaffney G . Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry. 2001; 40(2):222-9. DOI: 10.1097/00004583-200102000-00017. View

12.

Kovacs M, Devlin B . Internalizing disorders in childhood. J Child Psychol Psychiatry. 1998; 39(1):47-63. View

13.

Norberg M, Krystal J, Tolin D . A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry. 2008; 63(12):1118-26. DOI: 10.1016/j.biopsych.2008.01.012. View

14.

Castren E, Voikar V, Rantamaki T . Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2006; 7(1):18-21. DOI: 10.1016/j.coph.2006.08.009. View

15.

Branchi I . The double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. Psychoneuroendocrinology. 2010; 36(3):339-51. DOI: 10.1016/j.psyneuen.2010.08.011. View

16.

Sousa N, Lukoyanov N, Madeira M, Almeida O, Paula-Barbosa M . Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience. 2000; 97(2):253-66. DOI: 10.1016/s0306-4522(00)00050-6. View

17.

Thomsen P . Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases. J Child Adolesc Psychopharmacol. 1997; 7(3):157-66. DOI: 10.1089/cap.1997.7.157. View

18.

Grayson D, Kundakovic M, Sharma R . Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?. Mol Pharmacol. 2009; 77(2):126-35. DOI: 10.1124/mol.109.061333. View

19.

Faustino T, Almeida R, Andreatini R . [Medicinal plants for the treatment of generalized anxiety disorder: a review of controlled clinical studies]. Braz J Psychiatry. 2011; 32(4):429-36. DOI: 10.1590/s1516-44462010005000026. View

20.

Champagne D, Bagot R, van Hasselt F, Ramakers G, Meaney M, de Kloet E . Maternal care and hippocampal plasticity: evidence for experience-dependent structural plasticity, altered synaptic functioning, and differential responsiveness to glucocorticoids and stress. J Neurosci. 2008; 28(23):6037-45. PMC: 6670331. DOI: 10.1523/JNEUROSCI.0526-08.2008. View